/

Società

Me

Non verificato

Merck

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza

28 comunicati stampa

Guarda tutti i comunicati

24/11/2025

Industria

Attrezzature medico-sanitarie

Salute

Sanità

Medicina - Varie

Farmaceutica

Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis

Fonte

Emittente

1.00

0

28/10/2025

Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies

Fonte

Emittente

1.00

0

17/10/2025

Oncologia

Salute

Sanità

Medicina - Varie

Farmaceutica

Biotecnologia

Industria

Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT

Fonte

Emittente

1.00

0

15/10/2025

Merck to Acquire the Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio

Fonte

Emittente

1.00

0

23/09/2025

Merck and Siemens Deepen Strategic Partnership to Accelerate AI and Data-Driven Drug Discovery and Development

Fonte

Emittente

1.00

0

18/09/2025

Merck Opens Climate-Neutral €150 Million Filter Manufacturing Facility in Ireland

Fonte

Emittente

1.00

0

17/09/2025

Igiene alimentare

Salute

Sanità

Farmaceutica

Eventi

Industria

Merck to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025

Fonte

Emittente

1.00

0

02/09/2025

Farmaceutica

Scienza

Salute

Mercato del lavoro

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

Fonte

Emittente

1.00

0

15/07/2025

Merck Launches AAW™ Workstation to Advance Lab Automation

Fonte

Emittente

1.00

0

18/06/2025

Merck Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0